PREVENT fast-tracks vaccine development for diseases of major public health concern and bridges the gap between lab bench and market. PREVENT (Pan-Provincial Vaccine Enterprise) would like to hear from researchers and organizations that have potential to play a role in vaccine development.
Pooling the knowledge and resources of experts in public health, academic organizations and research institutes, the vaccine industry, and the investment community, PREVENT identifies promising vaccine candidates targeting Canada's public health priorities. PREVENT then works with industry partners to develop these vaccine candidates for the marketplace.
PREVENT conducts time and labour intensive preclinical and early-stage clinical trials for promising vaccine candidates, reducing the risk by facilitating critical mid-stage vaccine development. Thus PREVENT creates a pathway to commercialization, enabling and strengthening Canada's vaccine industry, promoting growth, investment and improved global competitiveness.
An incorporated Canadian non-profit organization, the PREVENT Centre of Excellence for Commercialization and Research partnership is led by an impressive body of expertise: a team of internationally recognized authorities on infectious diseases from VIDO/InterVac (SK), The Canadian Center for Vaccinology (NS), and the BC Centre for Disease Control (BC).
PREVENT would like to hear from others who are also at (or interested in being at) the forefront of downstream vaccine development in Canada.
